Orthopedics. 2022 Nov-Dec;45(6):e295-e302. doi: 10.3928/01477447-20220706-03. Epub 2022 Jul 12.
Cannabinoid compounds are being increasingly used as an analgesic adjuvant in the orthopedic population, but little data exist to either support or oppose this practice pattern. A review of all contemporary (2000-2020) studies on the use of cannabinoids in orthopedics is presented. Physicians and patients are optimistic that cannabinoids can decrease pain scores and perhaps opioid use; however, their application in orthopedics is not well characterized. In addition to the social stigma regarding the use of cannabis, there is limited high-quality evidence of the efficacy of cannabinoids in treating orthopedic-related pain. As cannabis becomes more accessible, well-designed trials are needed to better understand cannabinoids and guide orthopedic practice. [. 2022;45(6):e295-e302.].
大麻素化合物作为一种镇痛佐剂，在骨科人群中被越来越多地应用，但几乎没有数据支持或反对这种治疗模式。本文回顾了 2000 年至 2020 年所有关于大麻素在骨科中应用的研究。医生和患者都乐观地认为大麻素可以降低疼痛评分，甚至减少阿片类药物的使用；然而，它们在骨科中的应用尚未得到充分描述。除了使用大麻的社会耻辱感之外，大麻素治疗骨科相关疼痛的疗效的高质量证据也很有限。随着大麻的使用越来越方便，需要进行精心设计的试验来更好地了解大麻素并指导骨科实践。[临床骨科与研究杂志 2022 年 45 卷第 6 期 295-302 页]。
